Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

NSE/VENUSREM stock hub

NSE/VENUSREM has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/VENUSREMis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

13.5B

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/VENUSREM

In the news

Latest news · NSE/VENUSREM

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 24.9P50 32.4P75 45.7

Trailing P/E17.6

P25 24.8P50 35.9P75 56.9

ROEn/a

P25 6.3P50 13.6P75 18.1

ROIC18.9

P25 4.1P50 10.3P75 17.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/VENUSREM market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

184

Groups with data

Currency

INR

Showing 184 of 184 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	1,298
Employees Change	111%
Employees Change Percent	9.35
Enterprise value	INR 11.2B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	INE411B01019
Last refreshed	2026-05-10
Market cap	INR 13.5B
Price	INR 1,016
Price currency	INR
Rev Per Employee	5,414,838.21x
Sector	Healthcare
Sic	2834
Symbol	nse/VENUSREM
Website	https://www.venusremedies.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.67%
EV Earnings	14.74x
EV/EBIT	11.72x
EV/EBITDA	10.19x
EV/Sales	1.6x
P/B ratio	2.26x
P/E ratio	17.64x
P/S ratio	1.91x
PE Ratio10 Y	12.57x
PE Ratio3 Y	13.61x
PE Ratio5 Y	11.86x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	13.65%
EBITDA Margin	15.7%
Gross margin	47.04%
Gross Profit	INR 3.3B
Gross Profit Growth	31.82%
Gross Profit Growth Q	41.03%
Gross Profit Growth3 Y	17.74%
Gross Profit Growth5 Y	7.34%
Net Income	INR 762.8M
Net Income Growth	118.83%
Net Income Growth Q	30.51%
Net Income Growth Quarters	5%
Net Income Growth Years	2%
Net Income Growth3 Y	69.22%
Net Income Growth5 Y	29.1%
Pretax Margin	14.74%
Profit Margin	10.85%
Profit Per Employee	INR 587,710
Profitable Years	5
Roa5y	3.26
Roe5y	9.46
ROIC	18.94
Roic5y	5.52

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	27.82%
Cagr15y	11.53%
Cagr1y	235.37%
Cagr3y	74.86%
Cagr5y	25.02%
EPS Growth	118.9
EPS Growth Q	36.13
EPS Growth Quarters	5
EPS Growth Years	2
EPS Growth3 Y	69.06
EPS Growth5 Y	27.04
Revenue Growth	8.45x
Revenue Growth Q	1.92x
Revenue Growth Quarters	3x
Revenue Growth Years	2x
Revenue Growth3 Y	9.06x
Revenue Growth5 Y	5.73x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 2.4B
Debt	INR 143.8M
Debt EBITDA	INR 0.13
Debt Equity	INR 0.02
Equity	INR 5.9B
Interest Coverage	2,112.4
Net Cash	INR 2.2B
Net Cash By Market Cap	INR 16.45
Net Cash Growth	137.32%
Net Debt EBITDA	INR -2.01
Net Debt Equity	INR -0.37
Tangible Book Value	INR 4.9B
Tangible Book Value Per Share	INR 370
WACC	5.02

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.04%
Dividend per share	INR 0
Last Dividend	INR 3

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	1,063.31%
1Y total return	235.09%
200-day SMA	669.2
3Y total return	434.82%
50-day SMA	885.3
50-day SMA vs 200-day SMA	50over200
5Y total return	205.33%
All Time High	1,088.8
All Time High Change	-6.67%
All Time High Date	2026-04-15
All Time Low	18.8
All Time Low Change	5,305.05%
All Time Low Date	2019-07-19
ATR	51.89
Beta	0.15
Ch YTD	32.64
High	1,016.2
High52	1,088.8
High52 Date	2026-04-15
High52ch	-6.67%
Low	972.7
Low52	296
Low52 Date	2025-05-09
Low52ch	245.45%
Ma50ch	14.78%
Price vs 200-day SMA	51.85%
RSI	57.91
RSI Monthly	76.12
RSI Weekly	65.9
Sharpe ratio	2.55x
Sortino ratio	5.07
Total Return	0.04%
Tr YTD	32.64
Tr15y	414%
Tr1m	11.01%
Tr1w	3.27%
Tr3m	38.36%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 959.1M
Operating Income Growth	212.3
Operating Income Growth Q	139.1
Operating Income Growth3 Y	112.3
Operating Income Growth5 Y	20.53
Operating margin	13.65

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	6,367,420%
Shares Insiders	30.05%
Shares Institutions	1.13%
Shares Qo Q	-0.01%
Shares Yo Y	-0.04%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	68,326.6x
Bv Per Share	444.6
Ch10y	1,063.3
Ch15y	393.8
Ch1m	11.01
Ch1w	3.27
Ch1y	235.1
Ch3m	38.36
Ch3y	434.8
Ch5y	205.3
Ch6m	127.7
Change	5%
Change From Open	4.43
Close	967.8
Days Gap	0.54
Depreciation Amortization	144,608,500
Dollar Volume	81,939,287.6
Earnings Date	2026-05-26
EBIT	INR 959.1M
EBITDA	INR 1.1B
EPS	INR 57.08
F Score	2
Fiscal Year End	March
Founded	1,989
Graham Number	762.75285
Graham Upside	-24.94
Income Tax	INR 273M
Is Primary Listing	0
Last Earnings Date	2026-01-29
Last Report Date	2025-12-31
Lynch Fair Value	INR 1,440
Lynch Upside	41.74
Ma150	730.7
Ma150ch	39.06%
Ma20	989.8
Ma20ch	2.66%
Next Earnings Date	2026-05-26
Open	973
Position In Range	100
Price Date	2026-05-08
Price EBITDA	INR 12.19
Ptbv Ratio	2.72
Relative Volume	1.22x
Revenue	7,028,460,000x
Tax By Revenue	3.88x
Tax Rate	26.36%
Tr6m	127.68%
Volume	80,637

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does NSE/VENUSREM pay a dividend?

Capital-return profile for this ticker.

Performance

NSE/VENUSREM stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NSE/VENUSREM?

Insider, institutional, and short-interest positioning.

Institutional ownership

+1.1%

Share of float held by funds and institutions

Insider ownership

+30.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.0%

Negative means the company is buying back shares.

Technical

NSE/VENUSREM momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

57.9

Neutral momentum band

Price vs 200-day MA

+51.8%

50/200-day relationship not available

Beta (5Y)

0.15

Less volatile than the market

Sharpe ratio

2.55

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/VENUSREM

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/VENUSREM stock rating?

nse/VENUSREM is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/VENUSREM analysis?

The full report lives at /stocks/nse/VENUSREM/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/VENUSREM?

The latest report frames nse/VENUSREM around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/VENUSREM page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.